MHLW Starts Discussions Of New Rules For Internet Sales Of Drugs
This article was originally published in PharmAsia News
MHLW rulemaking group for OTC drugs, chaired by Associate Professor Ryuichi Yamamoto from the Tokyo Graduate School of Information Studies, had its first meeting Aug. 15 to begin making rules for the sale of OTC drugs on the Internet.
You may also be interested in...
CV Defense, the second launch in the firm’s new immune-support line (without cannabidiol), is built around palmitoylethanolamide and other nutrients and botanicals to “optimize immune response.” CV Sciences touts the immunity range as complementary to its PlusCBD brand, which is in the process of rolling out dozens of new products in updated packaging.
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.
US, EU and Canadian authorities recently discussed their approaches to rolling reviews of CMC applications for coronavirus vaccines.